Notice2021-15795
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 26, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Focus Group Testing to Effectively Plan and Tailor Cancer Prevention and Control Communication Campaigns. CDC is requesting a Revision to this Generic Clearance to include an additional cancer-related communications campaign, expand the modes of data collection to include online focus groups and in- depth interviews (in-person, phone, and online), and to focus on respondents from the general public.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 140 (Monday, July 26, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 140 (Monday, July 26, 2021)]
[Notices]
[Pages 40050-40051]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-15795]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-0800; Docket No. CDC-2021-0072]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Focus Group Testing to
Effectively Plan and Tailor Cancer Prevention and Control Communication
Campaigns. CDC is requesting a Revision to this Generic Clearance to
include an additional cancer-related communications campaign, expand
the modes of data collection to include online focus groups and in-
depth interviews (in-person, phone, and online), and to focus on
respondents from the general public.
DATES: CDC must receive written comments on or before September 24,
2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0072 by any of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://Regulations.gov">Regulations.gov</a>. Follow the
instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://Regulations.gov">Regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
<a href="/cdn-cgi/l/email-protection#1976747b597a7d7a377e766f"><span class="__cf_email__" data-cfemail="bbd4d6d9fbd8dfd895dcd4cd">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Focus Group Testing to Effectively Plan and Tailor Cancer
Prevention and Control Communications Campaigns--(OMB Control No. 0920-
0800, Exp. 10/31/2021)--Revision--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The mission of the CDC's Division of Cancer Prevention and Control
(DCPC) is to reduce the burden of cancer in the United States through
cancer prevention, reduction of risk, early detection, and improved
quality of life for cancer survivors. Toward this end, the DCPC
supports the scientific development and implementation of various
health communication campaigns with an emphasis on specific cancer
burdens.
This process requires testing of messages, concepts, and materials
prior to their final development and dissemination, as described in the
second step of the health communication process. The health
communication process is a scientific model developed by the U.S.
Department of Health and Human Services' National Cancer Institute to
guide sound campaign development. The communication literature supports
various data collection methods to conduct credible formative, concept,
message, and materials testing. This process ensures that the public
clearly understands cancer-specific information and concepts, are
motivated to take the desired action, and do not react negatively to
the messages. CDC is currently approved to collect information needed
to plan and tailor cancer communication campaigns (OMB Control No.
0920-0800, Exp. 10/31/2021), and seeks OMB approval to revise the
existing generic clearance to include another cancer-related
communications campaign, expand the modes of data collection to include
online focus groups and in-depth interviews (in-person, phone, and
online), and to focus on respondents from the general public.
Information collection will involve discussions to assess numerous
qualitative dimensions of cancer prevention and control messages
including, but not limited to, cancer knowledge, attitudes, beliefs,
behavioral intentions, information needs and sources, and compliance
with cancer screening as recommended by the United States Preventive
Services Task Force. Insights gained from these discussions will assist
in the development and/or refinement of future campaign messages and
materials. Communication campaigns and messages will vary according to
the type of cancer and the qualitative dimensions of the message
described above. A separate information collection
[[Page 40051]]
request will be submitted to OMB for approval of each discussion
activity. The request will describe the purpose of the activity and
include the customized information collection instruments.
OMB approval is requested for three years. There is no change in
burden hours or respondents. Participation is voluntary and there are
no costs to respondents except their time. CDC requests approval for an
estimated 1,680 annual burden hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
General Public................ Screening Form.. 1600 1 3/60 80
General Public................ Discussion Guide 800 1 2 1,600
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,680
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-15795 Filed 7-23-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 26, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.